Eupraxia Pharmaceuticals (EPRX) Other Working Capital Changes (2023 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted quarterly Other Working Capital Changes of $12059.0 for Q1 2026, up 915.92% year-over-year from $1187.0 in Q1 2025, and up 423.39% quarter-over-quarter from $2304.0 in Q3 2025.
Eupraxia Pharmaceuticals (EPRX) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Eupraxia Pharmaceuticals (EPRX) has reported Other Working Capital Changes for 4 consecutive years, with $12059.0 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Eupraxia Pharmaceuticals | 381.11 Mn | 379.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,059.00 |
| Mar 31, 2026 | 12,059.00 |
| Mar 31, 2026 | 12,059.00 |
| Sep 30, 2025 | 2,304.00 |
| Sep 30, 2025 | 2,304.00 |
| Sep 30, 2025 | 2,304.00 |
| Jun 30, 2025 | 867.00 |
| Jun 30, 2025 | 867.00 |
| Jun 30, 2025 | 867.00 |
| Mar 31, 2025 | 1,187.00 |
| Mar 31, 2025 | 1,187.00 |
| Mar 31, 2025 | 1,187.00 |
| Sep 30, 2024 | 1,835.00 |
| Sep 30, 2024 | 1,835.00 |
| Sep 30, 2024 | 1,835.00 |
| Jun 30, 2024 | 1,339.00 |
| Jun 30, 2024 | 1,339.00 |
| Jun 30, 2024 | 1,339.00 |
| Mar 31, 2024 | 1,998.00 |
| Mar 31, 2024 | 1,998.00 |